Pipeline
Our precisely delivered therapies – with their favorable tolerability profiles and systemic immunotherapeutic effects – have the potential to significantly improve survival while maintaining quality of life throughout all stages of disease.
We are evaluating our viral immunotherapies in a variety of solid tumors, including prostate, brain, lung and pancreatic cancer. For more information on our clinical studies, please visit our Clinical Trials page.